Ark Biotech specializes in advanced bioprocess simulation technologies that significantly enhance the efficiency and effectiveness of biomanufacturing. Their high-fidelity simulation software allows scientists to design, optimize, and scale bioprocesses rapidly, enabling them to conduct virtual bioreactor runs in seconds. This capability allows for the simulation of thousands of experiments in parallel, drastically reducing the time required for process development and minimizing the need for physical experiments. By leveraging insights from these simulations, users can optimize critical process parameters, improve overall process robustness, and predict cell culture performance across various scales and configurations.

The software is designed to support the entire bioprocess life cycle, from early-stage development to commercial operations, and is bioreactor agnostic, allowing customization of vessel geometries and configurations. Ark Biotech's technology also emphasizes data security, employing robust encryption and secure hosting practices to protect user data. By utilizing advanced model calibration methods, the software can generate valuable insights even with limited data, ensuring that processes are robust and adaptable to real-world variability. This holistic approach not only facilitates better decision-making but also helps identify and resolve potential scaling challenges proactively, ultimately driving success in bioprocess development.

United States

With an intelligent bioprocess platform, Ark helps today’s innovators make better decisions and accelerate development timelines dramatically — to bring transformational science to those who need it most.

Ark Biotech

Company Details